Cost-effectiveness analysis of HPV vaccination alongside cervical cancer screening programme in Slovenia

European Journal of Public Health
Marko ObradovicMitja Kos

Abstract

The objective of the present study is to evaluate the cost-effectiveness of human papillomavirus (HPV) vaccination alongside cervical cancer screening programme in Slovenia. A previously published Markov model representing natural history of HPV infection was adapted to Slovenian context. The model followed a cohort of 12-year-old girls to 85-year-old women. Two strategies were compared: HPV vaccination alongside conventional cytological screening versus screening alone. Analysis was performed from the health care payer perspective. Vaccination with screening compared with screening alone was associated with an incremental cost-effectiveness ratio (ICER) of 23,178 EUR per quality adjusted life-year (QALY) gained and 54,536 EUR per life-year gained (LYG) at the discounting rate of 5%. Sensitivity analyses demonstrated that the ICER was most sensitive to the need for booster dose and to different values of discount rates. In case the booster dose was assumed 10 years after initial vaccination, the ICER value was increased to 58,690 EUR per QALY. On the other hand, using lower values of discount rates than the base case 5% significantly reduced the ICER value. According to the cost-effectiveness thresholds of 30,000 EUR per QALY w...Continue Reading

References

Apr 16, 1998·Obstetrics and Gynecology·M F MitchellR Richards-Kortum
Jun 17, 2003·Journal of the National Cancer Institute. Monographs·F Xavier Bosch, Silvia de Sanjosé
Jul 5, 2003·Lancet·Steven E Waggoner
May 17, 2005·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Gary M CliffordJeanne M Pimenta
Jun 9, 2005·Nature Biotechnology·Malorye A Branca
Sep 22, 2005·PharmacoEconomics·J M BosLieven Annemans
Oct 26, 2005·Neurologic Clinics·Carlos H Schenck, Mark W Mahowald
Sep 12, 2006·Nature Biotechnology·Brian Vastag
Oct 28, 2006·PharmacoEconomics·Milton C Weinstein
May 15, 2007·The New England Journal of Medicine·UNKNOWN FUTURE II Study Group
Jan 26, 2008·International Journal of Technology Assessment in Health Care·Christine BergeronVanessa Remy
Feb 19, 2008·Cost Effectiveness and Resource Allocation : C/E·Shalini L KulasingamEvan R Myers
Oct 3, 2008·International Journal of Technology Assessment in Health Care·Bjørn Morten Hofmann
Aug 20, 2009·JAMA : the Journal of the American Medical Association·Barbara A SladeJohn Iskander

❮ Previous
Next ❯

Citations

Jul 4, 2013·BMC Infectious Diseases·Anneli UuskülaMatthew Pillsbury
Sep 9, 2015·Critical Reviews in Oncology/hematology·Riccardo A AudisioGian Vincenzo Zuccotti
Dec 7, 2018·Expert Review of Pharmacoeconomics & Outcomes Research·Dimitris KostarasKostas Athanasakis
Nov 8, 2011·International Journal of Public Health·Jennifer HollingsRoumyana Petrova-Benedict
Jan 1, 2015·International Journal of Technology Assessment in Health Care·Olena MandrikJohan L Severens

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.